SMB01361
Phosphoramide mustard cyclohexylamine
≥95% (HPLC)
Synonyme(s) :
N,N-Bis(2-Chloroethyl)phosphorodiamidic acid, cyclohexylamine, Friedman acid, cyclohexylamine, PAM cyclohexylamine, PM cyclohexylamine, PMC, Phosphamide mustard, Cyclohexylamine, Phosphorodiamidic mustard, Cyclohexylamine
Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Sélectionner une taille de conditionnement
1 MG
91,60 $
5 MG
366,00 $
91,60 $
Veuillez contacter notre Service Clients pour connaître la disponibilité de ce produit.
Sélectionner une taille de conditionnement
Changer de vue
1 MG
91,60 $
5 MG
366,00 $
About This Item
Formule linéaire :
C4H11Cl2N2O2P · C6H13N
Numéro CAS:
Numéro MDL:
Code UNSPSC :
12352209
Nomenclature NACRES :
NA.22
91,60 $
Veuillez contacter notre Service Clients pour connaître la disponibilité de ce produit.
Produits recommandés
Niveau de qualité
Essai
≥95% (HPLC)
Forme
solid
Température de stockage
-10 to -25°C
Chaîne SMILES
ClCCN(P(N)(O)=O)CCCl.NC1CCCCC1
InChI
1S/C6H13N.C4H11Cl2N2O2P/c7-6-4-2-1-3-5-6;5-1-3-8(4-2-6)11(7,9)10/h6H,1-5,7H2;1-4H2,(H3,7,9,10)
Clé InChI
BGTIPRUDEMNRIP-UHFFFAOYSA-N
1 of 4
Cet article | 8.02885 | 8.02948 | 29311 |
|---|---|---|---|
| form solid | form liquid | form liquid | form powder |
| storage temp. -10 to -25°C | storage temp. 2-30°C | storage temp. 2-30°C | storage temp. - |
| Quality Level 200 | Quality Level 200 | Quality Level 200 | Quality Level 200 |
Description générale
Phosphoramide mustard cyclohexanamine, a potent cytotoxic metabolite derived from the anticancer drug cyclophosphamide, acts as a remarkable alkylating agent. It is generated from cyclophosphamide through the ring-opened tautomer of the cytochrome P450 (CYP) isoform-formed intermediate 4-hydroxycyclophosphamide. This metabolite exerts its cytotoxic effects by inducing DNA crosslinking, guanine alkylation, and the formation of DNA-protein conjugates. In a concentration-dependent manner, it specifically targets HT-1080 human fibrosarcoma cells, triggering DNA damage. An essential contributor to Cyclophosphamide′s anticancer activity, Phosphoramide Mustard Cyclohexanamine exhibits great promise for cancer research, as it has the potential to induce DNA adduct formation and activate the ovarian DNA repair response in granulosa cells.
Application
Used in the development of chemotherapeutic drugs that are known to treat cancer.
Actions biochimiques/physiologiques
Phosphoramide mustard cyclohexanamine induces cytotoxicity by forming cross-linked DNA adducts that hinder DNA strand separation during replication. This compound destroys rapidly dividing cells and leads to DNA damage. In a study with rat ovarian granulosa cells (SIGCs), it reduced cell viability and increased DNA damage response (DDR) gene expression and protein levels. In animal models, it exhibited significant anticancer activity by inhibiting tumor growth. These findings highlight the potential of Phosphoramide mustard cyclohexanamine in cancer research[1][2]
Caractéristiques et avantages
- High quality compound suitable for multiple research applications
- Compatible with a wide variety of chromatographic and spectrometry techniques
Autres remarques
For additional information on our range of Biochemicals, please complete this form.
This product is intended for research purposes only, and it is not meant for human consumption.
Code de la classe de stockage
11 - Combustible Solids
Classe de danger pour l'eau (WGK)
WGK 3
Point d'éclair (°F)
Not applicable
Point d'éclair (°C)
Not applicable
Faites votre choix parmi les versions les plus récentes :
Certificats d'analyse (COA)
Lot/Batch Number
Vous ne trouvez pas la bonne version ?
Si vous avez besoin d'une version particulière, vous pouvez rechercher un certificat spécifique par le numéro de lot.
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
S A M Gernaat et al.
Scientific reports, 11(1), 2707-2707 (2021-02-03)
Cyclophosphamide (CPA) dosing by body surface area (BSA, m2) has been questioned as a predictor for individual drug exposure. This study investigated phosphoramide mustard-hemoglobin (PAM-Hb, pmol g-1 Hb) as a biomarker of CPA exposure in 135 female breast cancer patients
Kendra L Clark et al.
Biology of reproduction, 102(1), 248-260 (2019-08-23)
Ataxia-telangiectasia-mutated (ATM) protein recognizes and repairs DNA double strand breaks through activation of cell cycle checkpoints and DNA repair proteins. Atm gene mutations increase female reproductive cancer risk. Phosphoramide mustard (PM) induces ovarian DNA damage and destroys primordial follicles, and
Brain and plasma pharmacokinetics and anticancer activities of cyclophosphamide and phosphoramide mustard in the rat
Genka et al.
Cancer Chemotherapy and Pharmacology, 26, 1-7 (1990)
Julia Delahousse et al.
Journal for immunotherapy of cancer, 8(2) (2020-08-14)
Oxazaphosphorines (cyclophosphamide (CPA), ifosfamide (IFO)) are major alkylating agents of polychemotherapy protocols but limiting their toxicity and increasing their efficacy could be of major interest. Oxazaphosphorines are prodrugs that require an activation by cytochrome P450 (CYP). CPA is mainly metabolized
Shanthi Ganesan et al.
Toxicology and applied pharmacology, 282(3), 252-258 (2014-12-17)
Phosphoramide mustard (PM), the ovotoxic metabolite of the anti-cancer agent cyclophosphamide (CPA), destroys rapidly dividing cells by forming NOR-G-OH, NOR-G and G-NOR-G adducts with DNA, potentially leading to DNA damage. A previous study demonstrated that PM induces ovarian DNA damage
Active Filters
Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..
Contacter notre Service technique
